Ads
related to: gsk anoro ellipta- Type 2 COPD
Type 2 Inflammation Might Be
The Underlying Cause Of COPD
- COPD
Learn About COPD Patients
With Type 2 Inflammation
- Type 2 COPD
Search results
GSK's Q3 Earnings Beat, Ups 2022 Sales Outlook, Stock Up
Zacks via Yahoo Finance· 2 years agoGSK plc GSK reported third-quarter 2022 adjusted earnings of $1.09 per American depositary share...
GSK Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 2 weeks agoWe expect GSK's specialty products like Arexvy, Cabenuva, Juluca, Dovato, Nucala, Trelegy Ellipta and Shingrix to drive first-quarter sales performance.
GSK Beats on Q3 Earnings and Sales, Raises 2023 Guidance
Zacks via Yahoo Finance· 6 months agoGSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The...
Glaxo (GSK) Down 1.6% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 year agoIt has been about a month since the last earnings report for GSK (GSK). Shares have lost about 1.6%...
Why Is Glaxo (GSK) Up 6.7% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for GSK (GSK). Shares have added about 6.7% in...
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
Zacks via Yahoo Finance· 1 week agoGSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The...
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
Zacks via Yahoo Finance· 2 months agoGSK plc (GSK) plans to lower the prices of its entire inhaled respiratory products to $35 per month...
These Inhalers No Longer Cost More Than $35 Per Month
Verywell Health via Yahoo News· 1 month agoGrace Cary / Getty Images Fact checked by Nick Blackmer Key Takeaways Three major pharmaceutical...
Innoviva Inc (INVA) Reports Growth Amidst Challenges in Q4 and Full Year 2023 Financial Results
GuruFocus.com via Yahoo Finance· 2 months agoRevenue: Innoviva Inc (NASDAQ:INVA) reported a 35% year-over-year increase in net product revenues...
Entasis (ETTX) Stock Rises on Buyout Offer From Innoviva
Zacks via Yahoo Finance· 2 years agoEntasis Therapeutics Holdings Inc. ETTX announced that it has signed a definitive merger agreement...
Ad
related to: gsk anoro ellipta